Dirk Bremen - Concepedia

Author

Dirk Bremen

Ruhr University Bochum

Also Known As

D Bremen, D. Bremen, Dirk Bremen

Publications

482

Citations

H-Index

Concepts

All Affiliations

Ruhr University Bochum St. Josef-Hospital University of Tübingen

About

Dirk Bremen is an author at Ruhr University Bochum specializing in medicine, pharmacology, and parkinson disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	265
2	Neurology	3	3	233
3	Health Sciences	2	2	32
4	Biochemistry	1	1	54
5	Metabolism	1	1	54

Dirk Bremen

Publications

453

Citations

H-Index

Page 1

	Year	Citations
Impact of Gastric Emptying on Levodopa Pharmacokinetics in Parkinson Disease Patients Thomas M ller, C. Coronado Erdmann, Dirk Bremen, Clinical Neuropharmacology Levodopa PharmacokineticsMedicineParkinson DiseaseParkinson Disease PatientsNeuropharmacology	2006	128
Cooperative Interception of Neuronal Apoptosis by BCL‐2 and BAG‐1 Expression: Prevention of Caspase Activation and Reduced Production of Reactive Oxygen Species Jörg B. Schulz, Dirk Bremen, John C. Reed, Journal of Neurochemistry	1997	107
Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53 Michael Weller, Martin Trepel, Cornelia Grimmel, Neurological Research	1997	68
Inhibition of catechol‐<i>O</i>‐methyltransferase contributes to more stable levodopa plasma levels Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack, Movement Disorders Plasma Half-lifeMolecular PharmacologyBiochemistryNeurological DisorderMedicine	2005	54
Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack, Journal of Neural Transmission Pharmacokinetic BehaviourRepeat AdministrationMedicineParkinson DiseaseParkinson ’	2006	51
Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat Manfred Gerlach, Maarten van den Buuse, Charles D. Blaha, Naunyn-Schmiedeberg s Archives of Pharmacology Entacapone IncreasesPsychoactive DrugHealth SciencesAddictionMedicine	2004	20
Levodopa therapy with entacapone in daily clinical practice: results of a post-marketing surveillance study Andreas Kupsch, Thomas Trottenberg, Dirk Bremen Current Medical Research and Opinion	2003	13
Entacapone improves complex movement performance in patients with Parkinson’s disease Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack, Journal of Clinical Neuroscience Complex Movement PerformanceParkinson DiseaseMotor ControlRehabilitationNeuroscience	2006	12

Page 1